Globus Medical (GMED) said Thursday it has completed its all-cash $250 million acquisition of medical device company Nevro (NVRO).
The acquisition expands Globus Medical's footprint in the musculoskeletal market and unlocks a $2.5 billion market opportunity, the company said.
Nevro common stock ceased trading on the New York Stock Exchange before the market open on Thursday, Globus said.
Price: 72.15, Change: -3.35, Percent Change: -4.44
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。